Zeitschriftenartikel zum Thema „Dox-Induced Cardiotoxicity“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Dox-Induced Cardiotoxicity" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Sumneang, Natticha, Pongpan Tanajak und Thura Tun Oo. „Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity“. Molecules 28, Nr. 11 (24.05.2023): 4294. http://dx.doi.org/10.3390/molecules28114294.
Der volle Inhalt der QuelleAmmar, El-Sayed M., Shehta A. Said, Ghada M. Suddek und Sally L. El-Damarawy. „Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats“. Canadian Journal of Physiology and Pharmacology 89, Nr. 4 (April 2011): 269–76. http://dx.doi.org/10.1139/y11-020.
Der volle Inhalt der QuelleHamaamin, Karmand Salih, und Tavga Ahmed Aziz. „Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management“. Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 3 (10.12.2022): 87–97. http://dx.doi.org/10.54133/ajms.v3i.90.
Der volle Inhalt der QuelleZheng, Dong, Yi Zhang, Ming Zheng, Ting Cao, Grace Wang, Lulu Zhang, Rui Ni et al. „Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity“. Clinical Science 133, Nr. 13 (Juli 2019): 1505–21. http://dx.doi.org/10.1042/cs20181022.
Der volle Inhalt der QuelleZhang, Wei, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang und Congxin Huang. „Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3“. Oxidative Medicine and Cellular Longevity 2023 (14.01.2023): 1–23. http://dx.doi.org/10.1155/2023/9966355.
Der volle Inhalt der QuelleMao, Jin Ning, Ai Jun Li, Liang Ping Zhao, Lan Gao, Wei Ting Xu, Xiao Su Hong, Wen Ping Jiang und Jian Chang Chen. „PEG-PLGA Nanoparticles Entrapping Doxorubicin Reduced Doxorubicin-Induced Cardiotoxicity in Rats“. Advanced Materials Research 912-914 (April 2014): 263–68. http://dx.doi.org/10.4028/www.scientific.net/amr.912-914.263.
Der volle Inhalt der QuelleManeechote, Chayodom, Siriporn C. Chattipakorn und Nipon Chattipakorn. „Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity“. Pharmaceutics 15, Nr. 4 (07.04.2023): 1182. http://dx.doi.org/10.3390/pharmaceutics15041182.
Der volle Inhalt der QuelleKitakata, Hiroki, Jin Endo, Hidehiko Ikura, Hidenori Moriyama, Kohsuke Shirakawa, Yoshinori Katsumata und Motoaki Sano. „Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis“. International Journal of Molecular Sciences 23, Nr. 3 (26.01.2022): 1414. http://dx.doi.org/10.3390/ijms23031414.
Der volle Inhalt der Quelleda Cunha Menezes Souza, Leonardo, Meng Chen, Yuji Ikeno, Daisy Maria Fávero Salvadori und Yidong Bai. „The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine“. Traditional Medicine and Modern Medicine 03, Nr. 04 (Dezember 2020): 239–54. http://dx.doi.org/10.1142/s2575900020300076.
Der volle Inhalt der QuelleJiang, Lai, Yanping Gong, Yida Hu, Yangyang You, Jiawu Wang, Zhetao Zhang, Zeyuan Wei und Chaoliang Tang. „Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis“. Oxidative Medicine and Cellular Longevity 2020 (29.07.2020): 1–11. http://dx.doi.org/10.1155/2020/2405135.
Der volle Inhalt der QuelleCheng, Xiaoli, Dan Liu, Ruinan Xing, Haixu Song, Xiaoxiang Tian, Chenghui Yan und Yaling Han. „Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling“. BioMed Research International 2020 (19.10.2020): 1–13. http://dx.doi.org/10.1155/2020/5923572.
Der volle Inhalt der QuelleMiranda, Carlos J., Hortence Makui, Ricardo J. Soares, Marc Bilodeau, Jeannie Mui, Hajatollah Vali, Richard Bertrand, Nancy C. Andrews und Manuela M. Santos. „Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin“. Blood 102, Nr. 7 (01.10.2003): 2574–80. http://dx.doi.org/10.1182/blood-2003-03-0869.
Der volle Inhalt der QuelleJiao, Yuheng, Yanyan Li, Jiayan Zhang, Song Zhang, Yafang Zha und Jian Wang. „RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway“. Biomolecules 12, Nr. 2 (12.02.2022): 299. http://dx.doi.org/10.3390/biom12020299.
Der volle Inhalt der QuelleHu, Xiaoping, Huagang Liu, Zhiwei Wang, Zhipeng Hu und Luocheng Li. „miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice“. Oxidative Medicine and Cellular Longevity 2019 (03.11.2019): 1–13. http://dx.doi.org/10.1155/2019/1512326.
Der volle Inhalt der QuelleBhagat, Anchit, und Eugenie S. Kleinerman. „Neutrophils contribute to Doxorubicin-Induced Cardiotoxicity“. Journal of Immunology 206, Nr. 1_Supplement (01.05.2021): 111.23. http://dx.doi.org/10.4049/jimmunol.206.supp.111.23.
Der volle Inhalt der QuelleYu, Yangsheng, Degang Guo und Lin Zhao. „MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b“. Evidence-Based Complementary and Alternative Medicine 2022 (15.07.2022): 1–13. http://dx.doi.org/10.1155/2022/4364779.
Der volle Inhalt der QuelleMao, Meijiao, Wang Zheng, Bin Deng, Youhua Wang, Duan Zhou, Lin Shen, Wankang Niku und Na Zhang. „Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes“. PLOS ONE 18, Nr. 10 (12.10.2023): e0292124. http://dx.doi.org/10.1371/journal.pone.0292124.
Der volle Inhalt der QuelleZhao, Yintao, Jingjing Sun, Wei Zhang, Meng Peng, Jun Chen, Lu Zheng, Xiangqin Zhang, Haibo Yang und Yuan Liu. „Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2“. Oxidative Medicine and Cellular Longevity 2020 (03.08.2020): 1–11. http://dx.doi.org/10.1155/2020/3598715.
Der volle Inhalt der QuelleWang, Tao, Chuqiao Yuan, Jia Liu, Liangyan Deng, Wei Li, Junling He, Honglin Liu, Liping Qu, Jianming Wu und Wenjun Zou. „Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin“. International Journal of Molecular Sciences 24, Nr. 2 (04.01.2023): 897. http://dx.doi.org/10.3390/ijms24020897.
Der volle Inhalt der QuelleWang, Jingya, Lin Yao, Xiaoli Wu, Qi Guo, Shengxuan Sun, Jie Li, Guoqi Shi, Ruth B. Caldwell, R. William Caldwell und Yongjun Chen. „Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6“. Oxidative Medicine and Cellular Longevity 2021 (20.03.2021): 1–17. http://dx.doi.org/10.1155/2021/6628957.
Der volle Inhalt der QuelleLue, Yanhe, Chen Gao, Ronald Swerdloff, James Hoang, Rozeta Avetisyan, Yue Jia, Meng Rao et al. „Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity“. American Journal of Physiology-Heart and Circulatory Physiology 315, Nr. 3 (01.09.2018): H634—H643. http://dx.doi.org/10.1152/ajpheart.00155.2018.
Der volle Inhalt der QuelleLi, Jing, Huiping Liu, Srinivasan Ramachandran, Gregory B. Waypa, Jun-Jie Yin, Chang-Qing Li, Mei Han et al. „Grape Seed Proanthocyanidins Ameliorate Doxorubicin-Induced Cardiotoxicity“. American Journal of Chinese Medicine 38, Nr. 03 (Januar 2010): 569–84. http://dx.doi.org/10.1142/s0192415x10008068.
Der volle Inhalt der QuelleSmuder, Ashley J., Andreas N. Kavazis, Kisuk Min und Scott K. Powers. „Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals“. Journal of Applied Physiology 115, Nr. 2 (15.07.2013): 176–85. http://dx.doi.org/10.1152/japplphysiol.00924.2012.
Der volle Inhalt der QuelleAshour, Abdelkader E., Mohamed M. Sayed-Ahmed, Adel R. Abd-Allah, Hesham M. Korashy, Zaid H. Maayah, Hisham Alkhalidi, Mohammed Mubarak und Abdulqader Alhaider. „Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats“. Oxidative Medicine and Cellular Longevity 2012 (2012): 1–13. http://dx.doi.org/10.1155/2012/434195.
Der volle Inhalt der QuelleLi, Ling-Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Wei Deng und Qi-Zhu Tang. „Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway“. BioMed Research International 2020 (08.06.2020): 1–11. http://dx.doi.org/10.1155/2020/8593617.
Der volle Inhalt der QuelleLi, Siying, Wenjuan Wang, Ting Niu, Hui Wang, Bin Li, Lei Shao, Yimu Lai et al. „Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction“. Oxidative Medicine and Cellular Longevity 2014 (2014): 1–15. http://dx.doi.org/10.1155/2014/748524.
Der volle Inhalt der QuelleHaesen, Sibren, Manon Marie Jager, Aline Brillouet, Iris de Laat, Lotte Vastmans, Eline Verghote, Anouk Delaet et al. „Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity“. Antioxidants 13, Nr. 1 (17.01.2024): 112. http://dx.doi.org/10.3390/antiox13010112.
Der volle Inhalt der QuelleShan, Lingling, Yulong Huo, Siyu Li, Wanrong Li, Jing Wang, Yang Yang, Langzi Wang und Lin Chen. „Geraniin-Based Self-Assemble Nanoplatform for Antioxidation Reduced Cardiotoxicity and Tumor Synergistic Therapy“. Journal of Biomedical Nanotechnology 19, Nr. 5 (01.05.2023): 758–69. http://dx.doi.org/10.1166/jbn.2023.3580.
Der volle Inhalt der QuelleOno, Masaya, Yoichi Sunagawa, Saho Mochizuki, Takahiro Katagiri, Hidemichi Takai, Sonoka Iwashimizu, Kyoko Inai et al. „Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis“. Cancers 14, Nr. 3 (28.01.2022): 683. http://dx.doi.org/10.3390/cancers14030683.
Der volle Inhalt der QuelleJiang, Yu, Yanjuan Liu, Wen Xiao, Dandan Zhang, Xiehong Liu, Huiqiong Xiao, Sanli You und Lili Yuan. „Xinmailong Attenuates Doxorubicin-Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO-1“. Oxidative Medicine and Cellular Longevity 2021 (27.03.2021): 1–11. http://dx.doi.org/10.1155/2021/5896931.
Der volle Inhalt der QuelleTaylor, Justin R., und Kyra Harames. „Abstract 4771: Prevention of doxorubicin-induced cardiotoxicity by benfotiamine“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 4771. http://dx.doi.org/10.1158/1538-7445.am2023-4771.
Der volle Inhalt der QuelleKoczurkiewicz-Adamczyk, Paulina, Katarzyna Klaś, Agnieszka Gunia-Krzyżak, Kamil Piska, Kalina Andrysiak, Jacek Stępniewski, Sławomir Lasota et al. „Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin“. International Journal of Molecular Sciences 22, Nr. 12 (09.06.2021): 6217. http://dx.doi.org/10.3390/ijms22126217.
Der volle Inhalt der QuelleLiu, Yuzhou, Liying Zhou, Binbin Du, Yuan Liu, Junhui Xing, Sen Guo, Ling Li und Hongrui Chen. „Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway“. Oxidative Medicine and Cellular Longevity 2021 (06.08.2021): 1–18. http://dx.doi.org/10.1155/2021/9984330.
Der volle Inhalt der QuelleLee, Eun Ji, Woong Bi Jang, Jaewoo Choi, Hye Ji Lim, Sangmi Park, Vinoth Kumar Rethineswaran, Jong Seong Ha et al. „The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells“. International Journal of Molecular Sciences 24, Nr. 15 (28.07.2023): 12070. http://dx.doi.org/10.3390/ijms241512070.
Der volle Inhalt der QuelleEgwuatu, Ifeanyi Anthony, Chiadikobi Lawrence Ozoemena, Emeka Williams Ugwuishi, Christian Chiemeka Ozor, Augustine Oviosun und Favour Onwene. „Deciphering the Ameliorative Potential of 5, 7-dihydroxyflavone (Chrysin) on Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress in Rats“. Scholars International Journal of Anatomy and Physiology 6, Nr. 11 (23.11.2023): 181–90. http://dx.doi.org/10.36348/sijap.2023.v06i11.005.
Der volle Inhalt der QuelleAbdul Karim, Lubna Zuhair, Inam Sameh Arif und Fouad A. Al Saady. „Lipidomics application to explain acute cardiotoxicity induced by doxorubicin“. Al Mustansiriyah Journal of Pharmaceutical Sciences 19, Nr. 4 (01.12.2019): 161–69. http://dx.doi.org/10.32947/ajps.v19i4.647.
Der volle Inhalt der QuelleChen, Sida, Yang Huang, Suiqing Huang, Zhuoming Zhou, Kaizheng Liu, Jinyu Pan und Zhongkai Wu. „M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes“. PLOS ONE 18, Nr. 7 (27.07.2023): e0288422. http://dx.doi.org/10.1371/journal.pone.0288422.
Der volle Inhalt der QuelleHamada, Juri, Altansarnai Baasanjav, Natsumi Ono, Kazuya Murata, Koichiro Kako, Junji Ishida und Akiyoshi Fukamizu. „Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity“. American Journal of Physiology-Heart and Circulatory Physiology 308, Nr. 8 (15.04.2015): H931—H941. http://dx.doi.org/10.1152/ajpheart.00703.2013.
Der volle Inhalt der QuelleWang, Yuewen, Xu Chao, Fiaz ud Din Ahmad, Hailong Shi, Hania Mehboob und Waseem Hassan. „Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity“. Cardiology Research and Practice 2019 (23.12.2019): 1–8. http://dx.doi.org/10.1155/2019/7395239.
Der volle Inhalt der QuelleLi, Jun, Weiguo Wan, Tao Chen, Suiyang Tong, Xuejun Jiang und Wanli Liu. „miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice“. BioMed Research International 2019 (04.07.2019): 1–11. http://dx.doi.org/10.1155/2019/1528278.
Der volle Inhalt der QuelleGyongyosi, Alexandra, Nikolett Csaki, Agota Peto, Kitti Szoke, Ferenc Fenyvesi, Ildiko Bacskay und Istvan Lekli. „BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function“. International Journal of Molecular Sciences 24, Nr. 6 (09.03.2023): 5269. http://dx.doi.org/10.3390/ijms24065269.
Der volle Inhalt der QuelleAl-Shabanah, Othman A., Abdulaziz M. Aleisa, Mohamed M. Hafez, Salim S. Al-Rejaie, Abdulaziz A. Al-Yahya, Saleh A. Bakheet, Mohamed M. Al-Harbi und Mohamed M. Sayed-Ahmed. „Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model“. Oxidative Medicine and Cellular Longevity 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/619185.
Der volle Inhalt der QuelleRäsänen, Markus, Joni Degerman, Tuuli A. Nissinen, Ilkka Miinalainen, Risto Kerkelä, Antti Siltanen, Janne T. Backman et al. „VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection“. Proceedings of the National Academy of Sciences 113, Nr. 46 (31.10.2016): 13144–49. http://dx.doi.org/10.1073/pnas.1616168113.
Der volle Inhalt der QuelleHaesen, Sibren, Eline Verghote, Ellen Heeren, Esther Wolfs, Dorien Deluyker und Virginie Bito. „Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells“. Cells 13, Nr. 2 (09.01.2024): 120. http://dx.doi.org/10.3390/cells13020120.
Der volle Inhalt der QuelleLaw, David, Mitchel A. Magrini, Jacob A. Siedlik, Joan Eckerson, Kristen M. Drescher und Eric C. Bredahl. „Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity“. Nutrients 15, Nr. 18 (19.09.2023): 4048. http://dx.doi.org/10.3390/nu15184048.
Der volle Inhalt der QuelleLegi, Ashiq, Emma Rodriguez, Thomas K. Eckols, Cyrus Mistry und Prema Robinson. „Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity“. Cancers 13, Nr. 7 (06.04.2021): 1732. http://dx.doi.org/10.3390/cancers13071732.
Der volle Inhalt der QuelleTao, Rong-Hua, Masato Kobayashi, Yuanzheng Yang und Eugenie S. Kleinerman. „Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis“. Cancers 13, Nr. 11 (01.06.2021): 2740. http://dx.doi.org/10.3390/cancers13112740.
Der volle Inhalt der QuelleZhang, Wen-Bin, Xin Lai und Xu-Feng Guo. „Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis“. Oxidative Medicine and Cellular Longevity 2021 (26.01.2021): 1–14. http://dx.doi.org/10.1155/2021/8860883.
Der volle Inhalt der QuelleRong, Jing, Lizhong Li, Li Jing, Haiqin Fang und Shuangqing Peng. „JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes“. International Journal of Toxicology 35, Nr. 3 (02.11.2015): 317–26. http://dx.doi.org/10.1177/1091581815614261.
Der volle Inhalt der QuelleAshour, Osama M., Ashraf B. Abdel-Naim, Hossam M. Abdallah, Ayman A. Nagy, Ahmed M. Mohamadin und Essam A. Abdel-Sattar. „Evaluation of the Potential Cardioprotective Activity of Some Saudi Plants against Doxorubicin Toxicity“. Zeitschrift für Naturforschung C 67, Nr. 5-6 (01.06.2012): 297–307. http://dx.doi.org/10.1515/znc-2012-5-609.
Der volle Inhalt der Quelle